`Powered for penetration
`
`PROL0280370
`
`PAGE 1 OF 2
`
`SENJU EXHIBIT 2217
`INNOPHARMA v SENJU
`IPR2015-00903
`
`
`
`fORMUlATED. TO fACitiJATE CORNEAl PE~EJRATIO.N
`~· Advanced formulation df::liw::rs comeal penetration 1 3
`~ Pr·oven efficacy at e:1 towel' concentration than BRmJ1DAYr0 [bmrnfenac ophthalrnic solution) 0.09°/:1 1
`
`I
`
`I
`
`·£
`
`~· Powerful clearance-----Mon:; than twice as many patients ach!evf:;d compk;te cle;:H-ance of
`postoperative infl.armnat1on vs vehide at D:::Jy 15 [45SYo vs 2CL2'~'o; P<O.OOO 1] 1 2
`~· F<apid r·esolution-----F<apid n::duction of !nHamrnatlon follmv!ng cataract sur·gery"
`~· Pain free at Day ·t----J\pprm<imatety 4 of 5 patif::nts wf:;l-e p<:Jin free at Day F"*
`
`~· Designed for ocuiat comfott and convenience with QD efficac/·~
`~· No shaking n:~quired; solution delivers consistent dose 1n each dr·op15
`
`iMPORTANT RiSK lNFORMAT!ON ABOUT PROlENSA'"
`indications and Usage
`
`C [!7% :s 3 r:onstercidai
`::·:d:cClted for tile tre2trnent
`!f;duc:nn d ocular p.J:n :n
`
`lnf.Jrr:r:::-l'im:
`catar;ict sur:jery.
`~osage and Administration.
`:nst:IJ one
`:nrc tne d!if;c:f;G f}\'E cr:ce
`ccntir:ued c:n
`c:f sur:jery, ::nd
`
`1/V({mings and Precautions
`& Suifite
`reactic:r::;
`
`Adverse Reactkms
`ihe r';::st
`
`su:y:v.
`
`wer>;
`
`PROL0280371
`
`PAGE 2 OF 2